Glofitamab in B-NHL Using Mid-Therapy Intratumoral Transcriptomics

​ Conditions: Relapsed/Refractory Diffuse Large B-cell Lymphoma; Relapsed/Refractory Mantle Cell Lymphoma

Interventions: Biological: Glofitamab

Sponsors: Joshua Brody; Genentech, Inc.

Not yet recruiting Conditions: Relapsed/Refractory Diffuse Large B-cell Lymphoma; Relapsed/Refractory Mantle Cell Lymphoma
Interventions: Biological: Glofitamab
Sponsors: Joshua Brody; Genentech, Inc.
Not yet recruiting